StockData
Rigel Pharmaceuticals Inc logo

Rigel Pharmaceuticals Inc (RIGL) stock

RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30
$42.53−0.39 (-0.91%)

Close on Nov 18, 2026Market cap $794.46MP/E 2.7Yield –

Rigel Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Rigel Pharmaceuticals's pe ratio was 2.8× on Nov 11, 2026, against 8.2× a year earlier. Over the last 3 years it ranged from 1.4× to 131.5×, with a median of 9.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.8×−4.2
2025Dec 31, 20256.9×−73.2
2024Dec 31, 202480.1×+66.2
2012Feb 29, 201213.9×+2.9
2011Dec 30, 201111.0×–

More Rigel Pharmaceuticals figures

See a number that looks wrong?